BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19528198)

  • 1. Docosahexaenoic acid inhibits superoxide dismutase 1 gene transcription in human cancer cells: the involvement of peroxisome proliferator-activated receptor alpha and hypoxia-inducible factor-2alpha signaling.
    Tuller ER; Beavers CT; Lou JR; Ihnat MA; Benbrook DM; Ding WQ
    Mol Pharmacol; 2009 Sep; 76(3):588-95. PubMed ID: 19528198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARalpha signaling mediates the synergistic cytotoxicity of clioquinol and docosahexaenoic acid in human cancer cells.
    Tuller ER; Brock AL; Yu H; Lou JR; Benbrook DM; Ding WQ
    Biochem Pharmacol; 2009 May; 77(9):1480-6. PubMed ID: 19426685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid inhibits IL-6 expression via PPARγ-mediated expression of catalase in cerulein-stimulated pancreatic acinar cells.
    Song EA; Lim JW; Kim H
    Int J Biochem Cell Biol; 2017 Jul; 88():60-68. PubMed ID: 28483666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid inhibits TNFα-induced ICAM-1 expression by activating PPARα and autophagy in human endothelial cells.
    Lin HC; Lii CK; Lin AH; Li CC; Tsai CH; Pan SK; Yang YC; Huang CS; Reshi L; Chen HW
    Food Chem Toxicol; 2019 Dec; 134():110811. PubMed ID: 31499122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clofibrate PPARα activation reduces oxidative stress and improves ultrastructure and ventricular hemodynamics in no-flow myocardial ischemia.
    Ibarra-Lara L; Hong E; Soria-Castro E; Torres-Narváez JC; Pérez-Severiano F; Del Valle-Mondragón L; Cervantes-Pérez LG; Ramírez-Ortega M; Pastelín-Hernández GS; Sánchez-Mendoza A
    J Cardiovasc Pharmacol; 2012 Oct; 60(4):323-34. PubMed ID: 22691880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARalpha stimulation exerts a blood pressure lowering effect through different mechanisms in a time-dependent manner.
    Ibarra-Lara L; Cervantes-Pérez LG; Pérez-Severiano F; Del Valle L; Rubio-Ruíz E; Soria-Castro E; Pastelín-Hernández GS; Sánchez-Aguilar M; Martínez-Lazcano JC; Sánchez-Mendoza A
    Eur J Pharmacol; 2010 Feb; 627(1-3):185-93. PubMed ID: 19857485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of the PXR gene: identification and characterization of a functional peroxisome proliferator-activated receptor alpha binding site within the proximal promoter of PXR.
    Aouabdi S; Gibson G; Plant N
    Drug Metab Dispos; 2006 Jan; 34(1):138-44. PubMed ID: 16243957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter.
    Shimamoto Y; Hirota K; Fukamizu A
    Int J Mol Med; 2004 May; 13(5):729-33. PubMed ID: 15067378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.
    Inoue I; Goto S; Matsunaga T; Nakajima T; Awata T; Hokari S; Komoda T; Katayama S
    Metabolism; 2001 Jan; 50(1):3-11. PubMed ID: 11172467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of rat liver PPARα-FGF21 signaling by a docosahexaenoic acid and thyroid hormone combined protocol.
    Videla LA; Fernández V; Vargas R; Cornejo P; Tapia G; Varela N; Valenzuela R; Arenas A; Fernández J; Hernández-Rodas MC; Riquelme B
    Biofactors; 2016 Nov; 42(6):638-646. PubMed ID: 27248050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docosahexaenoic acid inhibits Helicobacter pylori-induced STAT3 phosphorylation through activation of PPARγ.
    Ji HG; Piao JY; Kim SJ; Kim DH; Lee HN; Na HK; Surh YJ
    Mol Nutr Food Res; 2016 Jun; 60(6):1448-57. PubMed ID: 27079734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clofibrate induces heme oxygenase 1 expression through a PPARα-independent mechanism in human cancer cells.
    Wang S; Hannafon BN; Zhou J; Ding WQ
    Cell Physiol Biochem; 2013; 32(5):1255-64. PubMed ID: 24247298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer.
    Chandran K; Goswami S; Sharma-Walia N
    Oncotarget; 2016 Mar; 7(13):15577-99. PubMed ID: 26621841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docosahexaenoic acid exerts anti-inflammatory action on human eosinophils through peroxisome proliferator-activated receptor-independent mechanisms.
    Tanigai T; Ueki S; Kihara J; Kamada R; Yamauchi Y; Sokal A; Takeda M; Ito W; Kayaba H; Adachi T; Ohta K; Chihara J
    Int Arch Allergy Immunol; 2012; 158(4):375-86. PubMed ID: 22487606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
    Pall H; Zaman MM; Andersson C; Freedman SD
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells.
    Yan J; Gong Y; Wang G; Gong Y; Burczynski FJ
    Biochem Cell Biol; 2010 Dec; 88(6):957-67. PubMed ID: 21102658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reducing environment stabilizes HIF-2alpha in SH-SY5Y cells under hypoxic conditions.
    Chen H; Shi H
    FEBS Lett; 2008 Nov; 582(28):3899-902. PubMed ID: 18957292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of cancer cells to docosahexaenoic acid-induced cytotoxicity: the potential importance of down-regulation of superoxide dismutase 1 expression.
    Ding WQ; Vaught JL; Yamauchi H; Lind SE
    Mol Cancer Ther; 2004 Sep; 3(9):1109-17. PubMed ID: 15367705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.
    Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG
    Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.